Trial Profile
A feasibility study of PankoMab-GEX ADC
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Gatipotuzumab (Primary)
- Indications Ovarian cancer; Solid tumours
- Focus Therapeutic Use
- 02 Nov 2017 New trial record